Topics:

NIH Granted Gene Therapy Patent

NIH Granted Gene Therapy Patent

WASHINGTON--The U.S. Patent and Trademark Office has awarded a broad patent on gene therapy to the National Institutes of Health. Six years after filing the application, NIH and its licensee, Genetic Therapy, Inc. of Gaithersburg, Maryland, can now use the patent for ex vivo human gene therapy.

In this technique, human cells are manipulated in the laboratory to express potentially therapeutic genes, which are then introduced into a patient to treat disease. Coinventors of the technique are Michael Blaese, MD, and Stephen A. Rosenberg, MD, PhD, both NIH scientists, and W. French Anderson, MD, a former NIH researcher now at the University of Southern California Norris Cancer Center.

 
Loading comments...
Please Wait 20 seconds or click here to close